+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Immunoglobulins Global Market Report 2021: COVID-19 Implications and Growth

  • ID: 5440767
  • Report
  • September 2021
  • Region: Global
  • 175 Pages
  • The Business Research Company

FEATURED COMPANIES

  • ADMA Biologics
  • Baxter International Inc.
  • Biotest AG
  • CSL Behring LLC
  • Grifols S.A.
  • Kedrion S.p.A.
Immunoglobulins Global Market Report 2021: COVID-19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global immunoglobulins market.







This report focuses on immunoglobulins market which is experiencing strong growth. The report gives a guide to the immunoglobulins market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for immunoglobulins? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Immunoglobulins market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider immunoglobulins market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The immunoglobulins market section of the report gives context. It compares the immunoglobulins market with other segments of the immunoglobulins market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, immunoglobulins indicators comparison.

Scope


Markets Covered:


  • By Product: IGG; IGA; IGM; IGE; IGD
  • By Mode Of Delivery: Intravenous Mode of Delivery; Subcutaneous Mode of Delivery
  • By Application: Hypogammaglobulinemia; Chronic Inflammatory demyelinating polyneuropathy (CIDP); Immunodeficiency Disease; Myasthenia Gravis; Idiopathic thrombocytopenic purpura (ITP); Others

Companies Mentioned:


Baxter International Inc.; BDI Pharma; CSL Behring LLC; Grifols S.A.; Octapharma

Countries:


Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


Five years historic and ten years forecast.

Data:


Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data segmentations:


country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Immunoglobulins Market

What is the estimated value of the Global Immunoglobulins Market?

The Global Immunoglobulins Market was estimated to be valued at $14.6 billion in 2021.

What is the growth rate of the Global Immunoglobulins Market?

The growth rate of the Global Immunoglobulins Market is 7.4%, with an estimated value of $19.4 billion by 2025.

What is the forecasted size of the Global Immunoglobulins Market?

The Global Immunoglobulins Market is estimated to be worth $19.4 billion by 2025.

Who are the key companies in the Global Immunoglobulins Market?

Key companies in the Global Immunoglobulins Market include Baxter International Inc., CSL Behring LLC, Grifols S.A., Octapharma, China Biologic Products Inc., Kedrion S.p.A., LFB group, Biotest AG and ADMA Biologics.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ADMA Biologics
  • Baxter International Inc.
  • Biotest AG
  • CSL Behring LLC
  • Grifols S.A.
  • Kedrion S.p.A.

1. Executive Summary2. Immunoglobulins Market Characteristics3. Immunoglobulins Market Trends and Strategies4. Impact Of COVID-19 On Immunoglobulins
5. Immunoglobulins Market Size and Growth
5.1. Global Immunoglobulins Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Immunoglobulins Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. Immunoglobulins Market Segmentation
6.1. Global Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • IGG
  • IGA
  • IGM
  • IGE
  • IGD
6.2. Global Immunoglobulins Market, Segmentation by Mode of Delivery, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Intravenous
  • Subcutaneous
6.3. Global Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hypogammaglobulinemia
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Immunodeficiency Disease
  • Myasthenia Gravis
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Others

7. Immunoglobulins Market Regional and Country Analysis
7.1. Global Immunoglobulins Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Immunoglobulins Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Immunoglobulins Market
8.1. Asia-Pacific Immunoglobulins Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Immunoglobulins Market
9.1. China Immunoglobulins Market Overview
9.2. China Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Immunoglobulins Market
10.1. India Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Immunoglobulins Market
11.1. Japan Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Immunoglobulins Market
12.1. Australia Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Immunoglobulins Market
13.1. Indonesia Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Immunoglobulins Market
14.1. South Korea Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Immunoglobulins Market
15.1. Western Europe Immunoglobulins Market Overview
15.2. Western Europe Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Immunoglobulins Market
16.1. UK Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Immunoglobulins Market
17.1. Germany Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Immunoglobulins Market
18.4. France Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Immunoglobulins Market
19.1. Eastern Europe Immunoglobulins Market Overview
19.2. Eastern Europe Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Immunoglobulins Market
20.1. Russia Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Immunoglobulins Market
21.1. North America Immunoglobulins Market Overview
21.2. North America Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Immunoglobulins Market
22.1. USA Immunoglobulins Market Overview
22.2. USA Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Immunoglobulins Market
23.1. South America Immunoglobulins Market Overview
23.2. South America Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Immunoglobulins Market
24.1. Brazil Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Immunoglobulins Market
25.1. Middle East Immunoglobulins Market Overview
25.2. Middle East Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Immunoglobulins Market
26.1. Africa Immunoglobulins Market Overview
26.2. Africa Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Immunoglobulins Market Competitive Landscape and Company Profiles
27.1. Immunoglobulins Market Competitive Landscape
27.2. Immunoglobulins Market Company Profiles
27.2.1. Baxter International Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. CSL Behring LLC
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Grifols S.A.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Octapharma
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. China Biologic Products Inc.
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Immunoglobulins Market29. Immunoglobulins Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ADMA Biologics
  • Baxter International Inc.
  • Biotest AG
  • CSL Behring LLC
  • Grifols S.A.
  • Kedrion S.p.A.
Major players in the immunoglobulins market are Baxter International Inc., CSL Behring LLC, Grifols S.A., Octapharma, China Biologic Products Inc., Kedrion S.p.A., LFB group, Biotest AG, Sanquin, ADMA Biologics, Option Care Enterprises, and Shanghai Raas Blood Products Co. Ltd.

The global immunoglobulins market is expected to grow from $12.89 billion in 2020 to $14.56 billion in 2021 at a compound annual growth rate (CAGR) of 13%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $19.36 billion in 2025 at a CAGR of 7.4%.

The immunoglobulins market consists of sales of immunoglobulins by entities (organizations, sole traders, and partnerships) that are used to measure the level of types of antibodies in the blood. Immunoglobulins or antibodies are glycoprotein molecules generated by plasma cells (white blood cells). They are an important aspect of the immune response because they recognize and bind to certain antigens, such as bacteria or viruses, and help to destroy them.

The main types of products in immunoglobulins are IGG, IGA, IGM, IGE, and IGD. Immunoglobulin G (IGG) is the primary stimulator of humoral immunity in extracellular fluids such as blood, lymph, and saliva. The immunoglobulins are delivered using the intravenous mode of delivery, subcutaneous mode of delivery and are used in hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency disease, myasthenia gravis, idiopathic thrombocytopenic purpura (ITP), others.

North America was the largest region in the immunoglobulins market in 2020. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The launch of new offices and laboratories to boost research and development activities is shaping the immunoglobulins market. Major companies operating in the immunoglobulins sector are focused on opening new laboratories for immunoglobulins to enhance the platform technology, pipeline development, and manufacturing capabilities. For instance, in February 2021, VectorY, a fully integrated gene therapy firm, has opened offices and laboratories in the Netherlands to develop novel vectorized antibodies for muscular and neurological illnesses. In this laboratory, VectorY creates exclusive and collaborative projects based on a revolutionary AAV platform and antibody-based targeted degradation technology. The company is developing a pipeline of new vectorized antibodies to treat muscle and CNS illnesses, to enhance delivery, durability, and accessibility of specific tissues and cells, to overcome the limits of present therapies.

In June 2020, CSL Behring, a US-based biopharmaceutical company acquired Vitaeris Inc. for an undisclosed amount. This acquisition accelerates the addition of clazakizumab, an anti-IL6 MAB currently in phase III development for the treatment of chronic active antibody-mediated rejection, into CSL Behring’s portfolio. Vitaeris Inc. is a US-based clinical-stage biotechnology company.

The increasing geriatric population drives the growth of the immunoglobulins market. The geriatric population is at high risk of infectious diseases and auto-immune diseases. The immunoglobulin test determines the body's ability to produce antibodies that protect it from bacteria, viruses, and allergies. According to the United Nations department of economic and social affairs (UN DESA), in 2020, the number of people aged over 65 was 727 million globally. By 2050, this figure is expected to have more than doubled, reaching over 1.5 billion people. The aging population is expected to rise from 9.3% in 2020 to 16% in 2050. Thus, the increasing geriatric population is expected to increase the demand for the immunoglobulins market during the forecast period.

The countries covered in the immunoglobulins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Baxter International Inc.
  • CSL Behring LLC
  • Grifols S.A.
  • Octapharma
  • China Biologic Products Inc.
  • Kedrion S.p.A.
  • LFB group
  • Biotest AG
  • Sanquin
  • ADMA Biologics
  • Option Care Enterprises
  • Shanghai Raas Blood Products Co. Ltd
Note: Product cover images may vary from those shown

Loading
LOADING...